ImetelChat

well bridge, one person's "cesspool" is another's oasis.

I am VERY thankful for ImetelChat.

Thank you BP, kmall and the rest of the serious contributors that make this oasis a safe haven for those that care about the future of Geron, Imetestat and the patients.

this sure sounds like an ex-US partner, while GERN goes it alone in the US...with the intention of acquiring another company after the stock price appreciates significantly from current price due to the partnership milestones and forth-coming imetelstat approval? total dreamland, but I've often wond...

Thank you BP....summarized perfectly.

Onward we go, tired....and together.

Whatever the truth behind the JnJ discontinuation, the facts and data support that they must surely still have some level of interest in Imetelstat, which is proving to be much more promising, impactful and lucrative than they originally thought back then. The smoke from 2018 is growing in intensity...

I'm cool with 1/8 the share price of JnJ.

I love the thought, Andrew!

I remain hopeful...it does feel as if things are more in motion than ever before.

If JnJ is truly still in the house, and many including myself feel this to be true, then the bidding starts at $5B at a minimum. This was their stated estimated valuation on public slide decks prior to discontinuation. In the years post-discontinuation, Geron appears to have done a nice job of incre...

great post, KMall!

I can assimilate to what you shared.

thank you...onward we go.

just passing along from YMB

Troy18 hours ago
@Andrew on Imetchat it may have came thru listed as Spence5745

This all would make a lot of sense if the private company ends up being a potential acquisition target of either GERON or a larger acquiring company of GERON due to a promising and/or synergistic therapy concept in early development. I believe Dr. Rizo is more of a scientist that can analyze and dev...

I believe it was Bridge-to-Sell - what happened to the recent post (either YMB or SA board) loosely tying Geron's potential value to Sierra's? It seems to have disappeared into the darkness. I'd like to revisit that in-light of this new acquisition and price. https://investor.sierraoncology.com/news...

We've discussed this a number of times as an important development to keep our eyes on and now, we have reached an inflection point. The FDA must act responsibly to help off-set this by approving Imetelstat in some capacity to provide relief. But, we're talking about the FDA, so.... https://www.cbsn...

This is an all-star post. I've come back to it more than a few times, as I regularly ponder the future of this company and my investment. Thank you HOTB!

As always, thank you BP!!

Juicy discussion here!

As always, thank you both (and to all the contributors across the various topic posts) for sharing your insight.

Agreed. thank you for articulating it properly BP.

MD Anderson the likely sponsor?!

I would happily donate to a GFM account.

This site is that important. Thank you BP for your insight and all you do for the ImetelChat community.

Most of the wishful talk about GERNs future has been centered on either a BP partnership and buyout, but a merger with another late stage biopharma, with other promising treatments in oncology, with a low stock float, would be quite interesting. BioPearl - is this what you are alluding to in your or...

Could this potentially impact Imetelstat in a favorable way? I did see a post on YMB implying as much, but I am struggling to understand exactly how/to what extent.